Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments. Today, the Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.
mediAVentures was involved for the production of the guidance video which is used by HCPs in order to clarify the workflow that needs to be followed during the drug administration process.
We liked this cooperation because it goes a little outside the typical scope of work, being a biotech company and being involved in the clinical stage now instead of the typical educational/training or marketing context. But most of all because of the dynamics and stimulating interactions of the professional team.